Female sex hormones affect susceptibility to systemic lupus erythematosus (SLE). To determine the effect of female sex hormones at onset of SLE on the survival of these patients, a retrospective survey was performed. The charts of 168 female SLE patients were evaluated to study the disease course, in particular the presence and kind of SLE criteria. Patients were classified as either belonging to the 'high female sex hormone at onset (HH )' or 'low female sex hormone at onset (LH )' group according to age at diagnosis. The statistics of the Dutch population, matched for age, were used to control for differences in life expectancy in these groups. A Cox regression model revealed that the relative mortality risk of HH patients vs HH controls was 4.2 times higher than the relative mortality risk of LH patients compared to LH controls. No differences in the frequency of SLE criteria between HH and LH patients were found that could explain the observed difference in mortality risk.
S observations suggest that oestrogens influence
Rotterdam and Juliana Children's Hospital in The Hague during the years 1985-1995 were studied. The the incidence and disease course of systemic lupus erythematosus (SLE ). The female to male ratio of SLE date of diagnosis of SLE and SLE criteria present at diagnosis or developing during disease course were patients is 9:1 in the reproductive years, but much lower in the prepubertal period [1] . Oral contraceptives noted. Patients were followed until the last known contact with their physician or the time of death. induced a 1.9 times higher chance of developing SLE in a prospective cohort study of 121 645 women [2] . It
Patients were classified as either belonging to the 'high female sex hormone at onset ( HH )' or 'low female sex has been reported that 16a-hydroxylation of oestradiol is enhanced in patients with SLE, resulting in an hormone at onset (LH )' group according to age at diagnosis. LH patients were women aged ∏14 yr and increased concentration of relatively potent oestrogens like oestriol [3] . An extensive review summarizes the Á51 yr. The HH group consisted of patients aged 17-47 yr. Twelve female patients, 15-16 and 48-50 yr studies performed to elucidate the possible pathogenesis of the influence of oestrogens on autoimmunity of age, were excluded because of possible doubt about their hormonal status. Life table analysis was per- [4] . Oestrogen receptors are identified on thymocytes, macrophages and endothelial cells. Furthermore, formed with Dutch health statistics, matched for age, serving as the control. Hazard rates were calculated oestrogens influence cytokine production and the expression of genes involved in apoptosis [4] . using Cox's regression model with hormonal status, the presence or absence of SLE and the interaction In summary, there is ample evidence that female sex hormones affect the incidence and disease course of term between these variables as variates. SLE. However, the influence of female sex hormones RESULTS at the onset of disease on prognosis has been scarcely described. Although a number of studies report a Baseline characteristics of both groups are depicted in Table I . A total of 114 HH patients (mean age worse prognosis in male lupus patients [5] [6] [7] [8] [9] , the presence of androgens in these patients is likely to be 29.3 yr, mean follow-up time 8.3 yr) were compared to 42 LH patients (24 patients ∏14 yr, mean age 11.3; of influence as well [10, 11] . Hence, the objective of this study is to investigate whether life expectancy TABLE I differs between females who have high and low concentrations of female sex hormones at the onset of SLE.
High female sex hormones at onset

PATIENTS AND METHODS
Baseline characteristics
Number of patients 114
The charts of 168 consecutive female SLE patients 18 patients Á51 yr, mean age 60.8; mean follow-up logical grounds and not laboratory testing. In an attempt to avoid misclassification, patients of 15-16 time for both groups 7.6 yr). SLE criteria that emerged at diagnosis or during follow-up are shown in Table II. and 48-50 yr of age were excluded. The survival of SLE patients mentioned here is an Although the difference in frequencies of photosensitivity and leucopenia reached statistical significance, none overestimation of the true survival. The patients included in this study visited the out-patient clinics remained significant after correction for multiple testing according to Bonferroni.
during the years 1985-1995. Hence, in some patients, the diagnosis of SLE was made before 1985. On In the comparison between Dutch controls and SLE patients, Cox regression analysis resulted in the followaverage, these patients probably have less severe disease, because the severe SLE cases diagnosed before ing relative mortality risks: LH SLE patients vs LH controls, 2.5; HH SLE patients vs HH controls, 10.5.
1985 are more likely to have died during the years from onset of SLE until 1985. However, no indication Thus, the relative mortality risk of HH patients vs HH controls was 4.2 times higher than the relative mortality is present that the time from diagnosis to entering the study period differs between the two sex hormone risk of LH patients compared to LH controls (P < 0.05).
groups. Furthermore, there might be additional confounding DISCUSSION factors not controlled for that can affect survival. For instance, some SLE manifestations might influence The objective of this study was to investigate the influence of female sex hormones at the time of diagprognosis. In a cohort of 408 SLE patients, mortality was associated with nephritis and seizures [12] . nosis on the survival of SLE patients. In order to achieve this goal, the patient population was divided Nevertheless, in this study, the frequencies of SLE criteria including nephritis and seizures did not differ into a HH group, consisting of female SLE patients who were in their reproductive years at the time of significantly between the two groups. The frequency of leucopenia, however, differed diagnosis (17-47 yr), and an LH group, consisting of female SLE patients ∏14 yr or Á51 yr at diagnosis. between groups. In the LH group, more patients had leucopenia than in the HH group. After Bonferroni Considering the fact that the HH and LH patients have different life expectancies, the statistics for the correction for multiple testing, only a trend remained. This is most likely caused by a difference in frequency Dutch population, matched for age, were added to the data set to control for this effect. Cox regression of neutropenia, since the frequency of lymphopenia did not differ. It has not been previously reported that analysis revealed that patients who developed SLE during the reproductive years have a 4.2 times higher neutropenia occurs more often in certain age groups. A possible explanation for this phenomenon might be relative mortality risk during any time of follow-up compared to the controls than LH patients.
that patients in the LH group have more active disease than those in the HH group. However, more active Given the retrospective character of this study, a few remarks have to be made. Misclassification of disease would probably lead to a higher mortality. This is in contradiction with the fact that HH patients patients cannot be ruled out since the patients were assigned to one of either groups based on epidemiohave a higher mortality risk than LH patients. 
